GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Indo US Bio-Tech Ltd (NSE:INDOUS) » Definitions » Cash From Discontinued Investing Activities

Indo US Bio-Tech (NSE:INDOUS) Cash From Discontinued Investing Activities : ₹0.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Indo US Bio-Tech Cash From Discontinued Investing Activities?

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Indo US Bio-Tech's cash from discontinued investing activities for the three months ended in Mar. 2025 was ₹0.0 Mil. It means Indo US Bio-Tech received ₹0.0 Mil from discontinued investing activities. Indo US Bio-Tech's cash from discontinued investing activities for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.0 Mil.


Indo US Bio-Tech Cash From Discontinued Investing Activities Historical Data

The historical data trend for Indo US Bio-Tech's Cash From Discontinued Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo US Bio-Tech Cash From Discontinued Investing Activities Chart

Indo US Bio-Tech Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cash From Discontinued Investing Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Indo US Bio-Tech Quarterly Data
Oct17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
Cash From Discontinued Investing Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Indo US Bio-Tech Cash From Discontinued Investing Activities Calculation

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Cash From Discontinued Investing Activities for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indo US Bio-Tech Cash From Discontinued Investing Activities Related Terms

Thank you for viewing the detailed overview of Indo US Bio-Tech's Cash From Discontinued Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


Indo US Bio-Tech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Indo US Bio-Tech Ltd (NSE:INDOUS) » Definitions » Cash From Discontinued Investing Activities
Traded in Other Exchanges
Address
Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061
Indo US Bio-Tech Ltd is engaged in the trading of agricultural seeds. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of agriculture crops. The company's product categories include vegetables; cotton seeds; oilseeds; spices seeds; pulses seeds and cereals seeds. The company has two segments which include Agricultural Activities and Trading Activities out of which it generates the key revenue from the Agricultural Activities.

Indo US Bio-Tech Headlines

No Headlines